 |
Cetero Research partners with SCORR Marketing
Kearney, Neb. (May 01, 2007) —Cetero Research of Cary, NC, and SCORR Marketing of Kearney, NE, recently partnered to showcase CORWatch, Cetero’s comprehensive cardiac safety suite of services.
The need for a thorough, well-designed and effectively executed QTc trial with statistical significance lies at the heart of submitting an NDA. Already a pioneer in providing accurate QTc data, Cetero recently strengthened its leadership position with the creation of CORWatch, an integrated suite of services tailored to cardiac safety trials in each phase of development. With more than 1,600 beds—including 146 dedicated hospital beds—a foundation of over 6,000 trials, and a patient database exceeding 100,000, Cetero is the industry leader in the delivery of cardiac safety assessment.
SCORR Marketing has over 50 years of combined, worldwide expertise focused on the clinical research and development organization industry. Specializing in marketing biotechnology, technology, engineering, construction, manufacturing, entertainment, education and hospitality related businesses, SCORR collaborates with clients to develop strategic marketing plans, tactical marketing tools and integrated communication systems.
“SCORR is an industry expert for marketing CROs,” states John Capicchioni, vice president of business development at Cetero Research. “We have partnered with members of the SCORR team in the past, so their team was a natural choice for developing our CORWatch branding campaign. I’ve been impressed with their strategic insight and creativity—it has been a winning combination for Cetero.”
“We are very enthusiastic about partnering with Cetero Research,” says Cinda Orr, president of SCORR Marketing. “Cetero is a specialist in the CRO industry both in terms of cardiac safety assessments and overall early clinical research capabilities and expertise. The strong leadership of Cetero’s management promises big things for this company’s future, and we are glad to be one of their partners.”
About Cetero Research
Cetero Research is headquartered in Cary, North Carolina, and offers a full spectrum of clinical research services to meet the needs of the pharmaceutical and biotechnology industries. Cetero’s capabilities and expertise are unparalleled in the industry with more than 1,600 beds—including 146 dedicated hospital beds—and a foundation of over 6,000 trials, as well as a patient database exceeding 100,000. The company also specializes in bioanalytical services, utilizing over 600 available assays and providing method development and validation along with sample analysis via LC/MS/MS and HPLC.
Cetero Research, the leading provider of early clinical and bioanalytical services, is the union of PRACS Institute, Ltd., Gateway Medical Research, Ba Research International and Allied Research International. Detailed information about the company is available at www.cetero.com or by calling 1-201-818-9346.
About SCORR Marketing
SCORR collaborates with energetic companies to develop “next-phase growth strategies” and a disciplined approach to marketing plans that insure solid incremental growth year after year, creating tangible results. SCORR’s team includes dedicated talent with worldwide experience in market development, public relations and communications, customer retention and development, corporate identity/branding, training and seminars, broadcast and print advertising, interactive/web design and development, graphic design/package design, as well as tradeshow/event planning and promotion. Detailed information about the company is available at www.scorrmarketing.com or by calling 1-308-237-5567.
|
